AstraZeneca Wants Scope Narrowed In Seroquel MDL
AstraZeneca LP is demanding that the judge overseeing the product liability litigation involving Seroquel limit further fact discovery to just the diabetes injury claims, arguing that the plaintiffs have had plenty...To view the full article, register now.
Already a subscriber? Click here to view full article